Placebo 250 mg

DRUG3 trials

Sponsors

Ache Laboratorios Farmaceuticos S.A., TNF Pharmaceuticals, Inc., Biocodex

Conditions

FrailtyFrailty in Older AdultsFrailty/SarcopeniaHealthyIBS (Irritable Bowel Syndrome)IBS, Mixed SymptomsIBS-D (Diarrhea-predominant)Sarcopenia in Elderly

Phase 1

Study to Assess Tolerability, Safety and Pharmacokinetics of a New Drug

TerminatedNCT01702675

Ache Laboratorios Farmaceuticos S.A.Healthy

Start: 2015-05-31End: 2017-06-30Updated: 2016-10-31

Phase 2

Safety and Efficacy of Isomyosamine in Reducing Inflammation and Treating Muscle Loss in Older Adults After Hip or Thigh Bone Fractures

Not yet recruitingNCT06942182

TNF Pharmaceuticals, Inc.Frailty, Frailty in Older Adults, Frailty/Sarcopenia +1

Start: 2025-05-01End: 2026-03-01Target: 60Updated: 2025-04-24

Phase 3

Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome

RecruitingNCT07168434

BiocodexIBS-D (Diarrhea-predominant), IBS (Irritable Bowel Syndrome), IBS, Mixed Symptoms

Start: 2025-10-22End: 2026-10-11Target: 406Updated: 2025-11-18